Is it really performing well?

Moderna shares rose nearly 2% in premarket trading

Moderna shares rose nearly 2% in premarket trading.The Food and Drug Administration granted full app
Moderna shares rose nearly 2% in premarket trading

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
  • woonws
    ·2022-02-01
    I also wonder
    Reply
    Report